Choose a Section All Most recent by Craig M. Kessler, MD SPONSORED CONTENT July 10, 2010 2 min read Save Is a Risk Evaluation and Mitigation Strategy necessary for erythropoiesis-stimulating agents? REMS presented in the wrong light.
